LANXESS worldwide

Corporate Website en | de

Asia

  • Australia en

  • China cn | en

  • India en

  • Indonesia en

  • Japan jp

  • Korea kr

  • Malaysia en

  • Pakistan en

  • Philippines en

  • Singapore

  • Thailand en

  • Vietnam en

EMEA

  • Austria en

  • Belgium nl

  • Czech en

  • France fr

  • Hungary en

  • Italy en

  • Netherlands en

  • Poland en

  • Russia en

  • Serbia en

  • Slovakia en

  • Spain en

  • Turkey en

  • United Arab Emirates en

  • United Kingdom en

Americas

Contact

LANXESS Canada Contacts

Contact our Sites in Canada

 

Media Inquiries

Global Press Releases

2018-06-18

LANXESS at VIV Europe 2018, Jaarbeurs-Utrecht, The Netherlands, stand AO11, hall 10, June 20 – 22, 2018

Biosecurity has bigger role to play in livestock production

Cologne – As concern about antibiotic resistance in humans grows, LANXESS – a leading specialty chemicals company for livestock production cleaning and disinfection products – have emphasized the key role that biosecurity must play in the industry’s future. “Disease prevention must always be the prime focus,” said Stephan Cho, Head of Market Segment Disinfection in the Material Protection Products business unit (MPP), at LANXESS. “Instead of waiting for problems to arise, we must take steps to build robust practices that prioritize hygiene and control. Biosecurity best practice, is our greatest weapon in helping to reduce the reliance on antibiotics in livestock meat production.”

Cho’s comments come ahead of LANXESS’s attendance at VIV Europe in Jaarbeurs, the Netherlands, the international conference on smart food production, convening every four years. The use of antibiotics has long been a contentious issue in livestock meat production. The US, for example, is estimated to use over 70 percent of its antibiotics on animals raised for human consumption, according to Review on Antimicrobial Resistance, 2016. Use of antibiotics in farm animals is not a problem in itself, but their use as routine treatment can lead to the development of pathogens acquiring resistance. Animal production systems with poor biosecurity present favorable conditions for the spread and persistence of antibiotic resistant bacteria – causing infections in animals and potential pressure on the future efficacy of antibiotics used in humans.

“Biosecurity is not just essential – it’s also a crucial element of a safe and cost-effective livestock production management program,” said Cho. “Reducing stress and lowering stocking densities are both methods to slow or halt disease-causing organism transmission but ultimately, there is always a risk, at which point best practice biosecurity protocols become critical.”

LANXESS are keen advocates for increased use of terminal and continuous biosecurity best practice and have recently launched the 360° approach to Biosecurity campaign. The campaign focuses on the key elements of biosecurity cleaning and disinfection; surfaces, air, water and equipment and highlights their proven and trusted portfolios of Biosolve heavy-duty cleaners and Virkon disinfectant solutions.  

With mounting external pressure on the industry to reduce excessive antimicrobial use – EU governments have suggested incentives for farmers to do just that – preventative measures are becoming more prevalent, as biosecurity programs become more accessible, practical, and backed by research. The costs incurred by compromised biosecurity are difficult to quantify, but the severest and most visible instances are not. For example, the Dutch Avian Influenza outbreak that arose in late 2016 led to ten million birds lost – resulting in costs exceeding €150m.

Unmeasured costs resulting from insufficient biosecurity best practices have the potential to cumulatively impact financial stability, even setting aside the development of antibiotic resistant “superbugs”, and their potentially catastrophic global effect. Many diseases are not easily apparent in the early stages, the only indicators being a reduction of growth, health, and productivity, all of which can be misdiagnosed or go unnoticed. These small losses add up and represent a severe financial loss to the livestock production industry.

“LANXESS are determined to bring the most effective cleaning and disinfectant solutions to livestock producers and provide advice and guidance on biosecurity best practice,” added Cho. “We have to make biosecurity practical for all. To this end, we have made huge investments in formulating cleaning and disinfection solutions that exceed the limitations of standard generic products. Our solutions will enable the entire supply chain to ensure they have a biosecurity management program that works for them – ultimately making best practice more convenient than ever, and ensuring greater productivity and financial stability.”

Read more about LANXESS and their commitment to biosecurity at www.virkon.com.

Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions, contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accept any liability whatsoever arising directly or indirectly from the use of this document.

LANXESS is a leading specialty chemicals company with sales of EUR 9.7 billion in 2017 and about 19,200 employees in 25 countries. The company is currently represented at 74 production sites worldwide. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. Through ARLANXEO, the joint venture with Saudi Aramco, LANXESS is also a leading supplier of synthetic rubber. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.

Contact

Ilona Kawan

Ilona Kawan
Spokesperson Trade and Technical Press

Phone: +49 221 8885 1684

Fax: +49 221 8885 4865

send E-Mail

Link

Download

  • Gallery